Global Lateral Flow Assay
Global Lateral Flow Assay

Lateral Flow Assay Comprehensive Study by Type (Kits & Reagents, Lateral Flow Readers, Digital/Mobile Readers, Benchtop Readers), End Users (Hospitals and Clinics, Diagnostic Laboratories, Pharmaceutical and Biotech Companies, Others), Clinical Tests (Clinical Testing { Infectious Diseases Testing, Cardiac Markers, Pregnancy & Fertility Testing, Drugs of Abuse Testing, Other}, Veterinary Diagnostics, Drug Development & Quality Testing, Food Safety & Environmental Safety), Technique (Competitive Assays, Sandwich Assays, Multiplex Detection Assays), Sales Channel (Hospital Pharmacies, Retail Pharmacies, Supermarket/Hypermarket, E-Commerce) Players and Region - Global Market Outlook to 2025

Lateral Flow Assay Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

May 2020 Edition 245 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Lateral Flow Assay Market Overview:
The lateral flow assay (LFA) is used for the detection and quantification of analytes in complex mixtures, where the sample is placed on a test device and the results are displayed within 5–30 min. These assays are widely used in hospitals and clinical laboratories for the qualitative and quantitative detection of specific antigens and antibodies. Low development costs and ease of production of lateral flow assays have resulted in the expansion of its applications to multiple fields due to which the market is booming at a rapid growth rate and is expected to increase maintain its continual expansion throughout the forecast period.

Market Drivers
  • High Prevalence of Infectious Diseases
  • Rapidly Increasing Geriatric Population
  • Growing Usage of Home-Based Lateral Flow Assay Devices

Market Trend
  • Integration of Microfluidic Technology in Lateral Flow Assays
  • Rising Demand for Multiplexed Lateral Flow Biosensors

Restraints
  • Reluctance Towards Changing Existing Diagnostic Practices

Opportunities
  • Evolving Applications of Lateral Flow Assays
  • Rising Demand for Lateral Flow Assays in the Food & Beverage Industry

Challenges
  • Limited Reimbursements for Lateral Flow Assay Products


Competitive Landscape:

Some of the key players profiled in the report are Abbott Laboratories (United States), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (United States), Siemens AG (Germany), Becton, Dickinson and Company (United States), bioMérieux (France), Bio-Rad Laboratories (United States), Thermo Fisher Scientific (United States), QIAGEN NV (Netherlands), PerkinElmer (United States), Hologic, Inc. (United States) and Quidel Corporation (United States). Analyst at AdvanceMarketAnalytics see United States, Germany, and China Players to retain maximum share of Global Lateral Flow Assay market by 2025. Considering Market by End Users, the sub-segment i.e. Hospitals and Clinics will boost the Lateral Flow Assay market. Considering Market by Clinical Tests, the sub-segment i.e. Clinical Testing { Infectious Diseases Testing, Cardiac Markers, Pregnancy & Fertility Testing, Drugs of Abuse Testing, Other} will boost the Lateral Flow Assay market. Considering Market by Technique, the sub-segment i.e. Competitive Assays will boost the Lateral Flow Assay market. Considering Market by Sales Channel , the sub-segment i.e. Hospital Pharmacies will boost the Lateral Flow Assay market.

In April 2020, Abbott Labs started the development of new coronavirus test kits that will enable United States for mass Covid-19 screening. This kit will have a “lateral flow” blood test that could provide mass testing to the general population and can deliver results within minutes.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Lateral Flow Assay market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Lateral Flow Assay market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Lateral Flow Assay Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Kits & Reagents
  • Lateral Flow Readers
  • Digital/Mobile Readers
  • Benchtop Readers
By End Users
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Pharmaceutical and Biotech Companies
  • Others

By Clinical Tests
  • Clinical Testing { Infectious Diseases Testing, Cardiac Markers, Pregnancy & Fertility Testing, Drugs of Abuse Testing, Other}
  • Veterinary Diagnostics
  • Drug Development & Quality Testing
  • Food Safety & Environmental Safety

By Technique
  • Competitive Assays
  • Sandwich Assays
  • Multiplex Detection Assays

By Sales Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Supermarket/Hypermarket
  • E-Commerce

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Prevalence of Infectious Diseases
      • 3.2.2. Rapidly Increasing Geriatric Population
      • 3.2.3. Growing Usage of Home-Based Lateral Flow Assay Devices
    • 3.3. Market Challenges
      • 3.3.1. Limited Reimbursements for Lateral Flow Assay Products
    • 3.4. Market Trends
      • 3.4.1. Integration of Microfluidic Technology in Lateral Flow Assays
      • 3.4.2. Rising Demand for Multiplexed Lateral Flow Biosensors
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Lateral Flow Assay, by Type, End Users, Clinical Tests, Technique, Sales Channel and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Lateral Flow Assay (Value)
      • 5.2.1. Global Lateral Flow Assay by: Type (Value)
        • 5.2.1.1. Kits & Reagents
        • 5.2.1.2. Lateral Flow Readers
        • 5.2.1.3. Digital/Mobile Readers
        • 5.2.1.4. Benchtop Readers
      • 5.2.2. Global Lateral Flow Assay by: End Users (Value)
        • 5.2.2.1. Hospitals and Clinics
        • 5.2.2.2. Diagnostic Laboratories
        • 5.2.2.3. Pharmaceutical and Biotech Companies
        • 5.2.2.4. Others
      • 5.2.3. Global Lateral Flow Assay by: Clinical Tests (Value)
        • 5.2.3.1. Clinical Testing { Infectious Diseases Testing, Cardiac Markers, Pregnancy & Fertility Testing, Drugs of Abuse Testing, Other}
        • 5.2.3.2. Veterinary Diagnostics
        • 5.2.3.3. Drug Development & Quality Testing
        • 5.2.3.4. Food Safety & Environmental Safety
      • 5.2.4. Global Lateral Flow Assay by: Technique (Value)
        • 5.2.4.1. Competitive Assays
        • 5.2.4.2. Sandwich Assays
        • 5.2.4.3. Multiplex Detection Assays
      • 5.2.5. Global Lateral Flow Assay Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Lateral Flow Assay (Volume)
      • 5.3.1. Global Lateral Flow Assay by: Type (Volume)
        • 5.3.1.1. Kits & Reagents
        • 5.3.1.2. Lateral Flow Readers
        • 5.3.1.3. Digital/Mobile Readers
        • 5.3.1.4. Benchtop Readers
      • 5.3.2. Global Lateral Flow Assay by: End Users (Volume)
        • 5.3.2.1. Hospitals and Clinics
        • 5.3.2.2. Diagnostic Laboratories
        • 5.3.2.3. Pharmaceutical and Biotech Companies
        • 5.3.2.4. Others
      • 5.3.3. Global Lateral Flow Assay by: Clinical Tests (Volume)
        • 5.3.3.1. Clinical Testing { Infectious Diseases Testing, Cardiac Markers, Pregnancy & Fertility Testing, Drugs of Abuse Testing, Other}
        • 5.3.3.2. Veterinary Diagnostics
        • 5.3.3.3. Drug Development & Quality Testing
        • 5.3.3.4. Food Safety & Environmental Safety
      • 5.3.4. Global Lateral Flow Assay by: Technique (Volume)
        • 5.3.4.1. Competitive Assays
        • 5.3.4.2. Sandwich Assays
        • 5.3.4.3. Multiplex Detection Assays
      • 5.3.5. Global Lateral Flow Assay Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Lateral Flow Assay (Price)
      • 5.4.1. Global Lateral Flow Assay by: Type (Price)
  • 6. Lateral Flow Assay: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. F. Hoffmann-La Roche (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Danaher Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Siemens AG (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Becton, Dickinson and Company (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BioMérieux (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bio-Rad Laboratories (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Thermo Fisher Scientific (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. QIAGEN NV (Netherlands)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. PerkinElmer (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Hologic, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Quidel Corporation (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Lateral Flow Assay Sale, by Type, End Users, Clinical Tests, Technique, Sales Channel and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Lateral Flow Assay (Value)
      • 7.2.1. Global Lateral Flow Assay by: Type (Value)
        • 7.2.1.1. Kits & Reagents
        • 7.2.1.2. Lateral Flow Readers
        • 7.2.1.3. Digital/Mobile Readers
        • 7.2.1.4. Benchtop Readers
      • 7.2.2. Global Lateral Flow Assay by: End Users (Value)
        • 7.2.2.1. Hospitals and Clinics
        • 7.2.2.2. Diagnostic Laboratories
        • 7.2.2.3. Pharmaceutical and Biotech Companies
        • 7.2.2.4. Others
      • 7.2.3. Global Lateral Flow Assay by: Clinical Tests (Value)
        • 7.2.3.1. Clinical Testing { Infectious Diseases Testing, Cardiac Markers, Pregnancy & Fertility Testing, Drugs of Abuse Testing, Other}
        • 7.2.3.2. Veterinary Diagnostics
        • 7.2.3.3. Drug Development & Quality Testing
        • 7.2.3.4. Food Safety & Environmental Safety
      • 7.2.4. Global Lateral Flow Assay by: Technique (Value)
        • 7.2.4.1. Competitive Assays
        • 7.2.4.2. Sandwich Assays
        • 7.2.4.3. Multiplex Detection Assays
      • 7.2.5. Global Lateral Flow Assay Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Lateral Flow Assay (Volume)
      • 7.3.1. Global Lateral Flow Assay by: Type (Volume)
        • 7.3.1.1. Kits & Reagents
        • 7.3.1.2. Lateral Flow Readers
        • 7.3.1.3. Digital/Mobile Readers
        • 7.3.1.4. Benchtop Readers
      • 7.3.2. Global Lateral Flow Assay by: End Users (Volume)
        • 7.3.2.1. Hospitals and Clinics
        • 7.3.2.2. Diagnostic Laboratories
        • 7.3.2.3. Pharmaceutical and Biotech Companies
        • 7.3.2.4. Others
      • 7.3.3. Global Lateral Flow Assay by: Clinical Tests (Volume)
        • 7.3.3.1. Clinical Testing { Infectious Diseases Testing, Cardiac Markers, Pregnancy & Fertility Testing, Drugs of Abuse Testing, Other}
        • 7.3.3.2. Veterinary Diagnostics
        • 7.3.3.3. Drug Development & Quality Testing
        • 7.3.3.4. Food Safety & Environmental Safety
      • 7.3.4. Global Lateral Flow Assay by: Technique (Volume)
        • 7.3.4.1. Competitive Assays
        • 7.3.4.2. Sandwich Assays
        • 7.3.4.3. Multiplex Detection Assays
      • 7.3.5. Global Lateral Flow Assay Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Lateral Flow Assay (Price)
      • 7.4.1. Global Lateral Flow Assay by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Lateral Flow Assay: by Type(USD Million)
  • Table 2. Lateral Flow Assay Kits & Reagents , by Region USD Million (2014-2019)
  • Table 3. Lateral Flow Assay Lateral Flow Readers , by Region USD Million (2014-2019)
  • Table 4. Lateral Flow Assay Digital/Mobile Readers , by Region USD Million (2014-2019)
  • Table 5. Lateral Flow Assay Benchtop Readers , by Region USD Million (2014-2019)
  • Table 6. Lateral Flow Assay: by End Users(USD Million)
  • Table 7. Lateral Flow Assay Hospitals and Clinics , by Region USD Million (2014-2019)
  • Table 8. Lateral Flow Assay Diagnostic Laboratories , by Region USD Million (2014-2019)
  • Table 9. Lateral Flow Assay Pharmaceutical and Biotech Companies , by Region USD Million (2014-2019)
  • Table 10. Lateral Flow Assay Others , by Region USD Million (2014-2019)
  • Table 11. Lateral Flow Assay: by Clinical Tests(USD Million)
  • Table 12. Lateral Flow Assay Clinical Testing { Infectious Diseases Testing, Cardiac Markers, Pregnancy & Fertility Testing, Drugs of Abuse Testing, Other} , by Region USD Million (2014-2019)
  • Table 13. Lateral Flow Assay Veterinary Diagnostics , by Region USD Million (2014-2019)
  • Table 14. Lateral Flow Assay Drug Development & Quality Testing , by Region USD Million (2014-2019)
  • Table 15. Lateral Flow Assay Food Safety & Environmental Safety , by Region USD Million (2014-2019)
  • Table 16. Lateral Flow Assay: by Technique(USD Million)
  • Table 17. Lateral Flow Assay Competitive Assays , by Region USD Million (2014-2019)
  • Table 18. Lateral Flow Assay Sandwich Assays , by Region USD Million (2014-2019)
  • Table 19. Lateral Flow Assay Multiplex Detection Assays , by Region USD Million (2014-2019)
  • Table 20. South America Lateral Flow Assay, by Country USD Million (2014-2019)
  • Table 21. South America Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 22. South America Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 23. South America Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 24. South America Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 25. South America Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 26. Brazil Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 27. Brazil Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 28. Brazil Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 29. Brazil Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 30. Brazil Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 31. Argentina Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 32. Argentina Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 33. Argentina Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 34. Argentina Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 35. Argentina Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 36. Rest of South America Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 37. Rest of South America Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 38. Rest of South America Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 39. Rest of South America Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 40. Rest of South America Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 41. Asia Pacific Lateral Flow Assay, by Country USD Million (2014-2019)
  • Table 42. Asia Pacific Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 43. Asia Pacific Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 44. Asia Pacific Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 45. Asia Pacific Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 46. Asia Pacific Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 47. China Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 48. China Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 49. China Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 50. China Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 51. China Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 52. Japan Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 53. Japan Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 54. Japan Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 55. Japan Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 56. Japan Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 57. India Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 58. India Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 59. India Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 60. India Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 61. India Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 62. South Korea Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 63. South Korea Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 64. South Korea Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 65. South Korea Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 66. South Korea Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 67. Taiwan Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 68. Taiwan Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 69. Taiwan Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 70. Taiwan Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 71. Taiwan Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 72. Australia Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 73. Australia Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 74. Australia Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 75. Australia Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 76. Australia Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 77. Rest of Asia-Pacific Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 78. Rest of Asia-Pacific Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 79. Rest of Asia-Pacific Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 80. Rest of Asia-Pacific Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 81. Rest of Asia-Pacific Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 82. Europe Lateral Flow Assay, by Country USD Million (2014-2019)
  • Table 83. Europe Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 84. Europe Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 85. Europe Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 86. Europe Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 87. Europe Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 88. Germany Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 89. Germany Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 90. Germany Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 91. Germany Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 92. Germany Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 93. France Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 94. France Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 95. France Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 96. France Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 97. France Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 98. Italy Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 99. Italy Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 100. Italy Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 101. Italy Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 102. Italy Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 103. United Kingdom Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 104. United Kingdom Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 105. United Kingdom Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 106. United Kingdom Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 107. United Kingdom Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 108. Netherlands Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 109. Netherlands Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 110. Netherlands Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 111. Netherlands Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 112. Netherlands Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 113. Rest of Europe Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 114. Rest of Europe Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 115. Rest of Europe Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 116. Rest of Europe Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 117. Rest of Europe Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 118. MEA Lateral Flow Assay, by Country USD Million (2014-2019)
  • Table 119. MEA Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 120. MEA Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 121. MEA Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 122. MEA Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 123. MEA Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 124. Middle East Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 125. Middle East Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 126. Middle East Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 127. Middle East Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 128. Middle East Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 129. Africa Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 130. Africa Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 131. Africa Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 132. Africa Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 133. Africa Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 134. North America Lateral Flow Assay, by Country USD Million (2014-2019)
  • Table 135. North America Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 136. North America Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 137. North America Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 138. North America Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 139. North America Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 140. United States Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 141. United States Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 142. United States Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 143. United States Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 144. United States Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 145. Canada Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 146. Canada Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 147. Canada Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 148. Canada Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 149. Canada Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 150. Mexico Lateral Flow Assay, by Type USD Million (2014-2019)
  • Table 151. Mexico Lateral Flow Assay, by End Users USD Million (2014-2019)
  • Table 152. Mexico Lateral Flow Assay, by Clinical Tests USD Million (2014-2019)
  • Table 153. Mexico Lateral Flow Assay, by Technique USD Million (2014-2019)
  • Table 154. Mexico Lateral Flow Assay, by Sales Channel USD Million (2014-2019)
  • Table 155. Lateral Flow Assay Sales: by Type(K Units)
  • Table 156. Lateral Flow Assay Sales Kits & Reagents , by Region K Units (2014-2019)
  • Table 157. Lateral Flow Assay Sales Lateral Flow Readers , by Region K Units (2014-2019)
  • Table 158. Lateral Flow Assay Sales Digital/Mobile Readers , by Region K Units (2014-2019)
  • Table 159. Lateral Flow Assay Sales Benchtop Readers , by Region K Units (2014-2019)
  • Table 160. Lateral Flow Assay Sales: by End Users(K Units)
  • Table 161. Lateral Flow Assay Sales Hospitals and Clinics , by Region K Units (2014-2019)
  • Table 162. Lateral Flow Assay Sales Diagnostic Laboratories , by Region K Units (2014-2019)
  • Table 163. Lateral Flow Assay Sales Pharmaceutical and Biotech Companies , by Region K Units (2014-2019)
  • Table 164. Lateral Flow Assay Sales Others , by Region K Units (2014-2019)
  • Table 165. Lateral Flow Assay Sales: by Clinical Tests(K Units)
  • Table 166. Lateral Flow Assay Sales Clinical Testing { Infectious Diseases Testing, Cardiac Markers, Pregnancy & Fertility Testing, Drugs of Abuse Testing, Other} , by Region K Units (2014-2019)
  • Table 167. Lateral Flow Assay Sales Veterinary Diagnostics , by Region K Units (2014-2019)
  • Table 168. Lateral Flow Assay Sales Drug Development & Quality Testing , by Region K Units (2014-2019)
  • Table 169. Lateral Flow Assay Sales Food Safety & Environmental Safety , by Region K Units (2014-2019)
  • Table 170. Lateral Flow Assay Sales: by Technique(K Units)
  • Table 171. Lateral Flow Assay Sales Competitive Assays , by Region K Units (2014-2019)
  • Table 172. Lateral Flow Assay Sales Sandwich Assays , by Region K Units (2014-2019)
  • Table 173. Lateral Flow Assay Sales Multiplex Detection Assays , by Region K Units (2014-2019)
  • Table 174. South America Lateral Flow Assay Sales, by Country K Units (2014-2019)
  • Table 175. South America Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 176. South America Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 177. South America Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 178. South America Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 179. South America Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 180. Brazil Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 181. Brazil Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 182. Brazil Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 183. Brazil Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 184. Brazil Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 185. Argentina Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 186. Argentina Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 187. Argentina Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 188. Argentina Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 189. Argentina Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 190. Rest of South America Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 191. Rest of South America Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 192. Rest of South America Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 193. Rest of South America Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 194. Rest of South America Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 195. Asia Pacific Lateral Flow Assay Sales, by Country K Units (2014-2019)
  • Table 196. Asia Pacific Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 197. Asia Pacific Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 198. Asia Pacific Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 199. Asia Pacific Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 200. Asia Pacific Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 201. China Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 202. China Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 203. China Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 204. China Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 205. China Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 206. Japan Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 207. Japan Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 208. Japan Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 209. Japan Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 210. Japan Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 211. India Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 212. India Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 213. India Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 214. India Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 215. India Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 216. South Korea Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 217. South Korea Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 218. South Korea Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 219. South Korea Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 220. South Korea Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 221. Taiwan Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 222. Taiwan Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 223. Taiwan Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 224. Taiwan Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 225. Taiwan Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 226. Australia Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 227. Australia Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 228. Australia Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 229. Australia Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 230. Australia Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 231. Rest of Asia-Pacific Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 232. Rest of Asia-Pacific Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 233. Rest of Asia-Pacific Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 234. Rest of Asia-Pacific Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 235. Rest of Asia-Pacific Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 236. Europe Lateral Flow Assay Sales, by Country K Units (2014-2019)
  • Table 237. Europe Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 238. Europe Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 239. Europe Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 240. Europe Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 241. Europe Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 242. Germany Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 243. Germany Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 244. Germany Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 245. Germany Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 246. Germany Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 247. France Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 248. France Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 249. France Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 250. France Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 251. France Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 252. Italy Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 253. Italy Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 254. Italy Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 255. Italy Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 256. Italy Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 257. United Kingdom Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 258. United Kingdom Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 259. United Kingdom Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 260. United Kingdom Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 261. United Kingdom Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 262. Netherlands Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 263. Netherlands Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 264. Netherlands Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 265. Netherlands Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 266. Netherlands Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 267. Rest of Europe Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 268. Rest of Europe Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 269. Rest of Europe Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 270. Rest of Europe Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 271. Rest of Europe Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 272. MEA Lateral Flow Assay Sales, by Country K Units (2014-2019)
  • Table 273. MEA Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 274. MEA Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 275. MEA Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 276. MEA Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 277. MEA Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 278. Middle East Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 279. Middle East Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 280. Middle East Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 281. Middle East Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 282. Middle East Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 283. Africa Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 284. Africa Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 285. Africa Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 286. Africa Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 287. Africa Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 288. North America Lateral Flow Assay Sales, by Country K Units (2014-2019)
  • Table 289. North America Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 290. North America Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 291. North America Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 292. North America Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 293. North America Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 294. United States Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 295. United States Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 296. United States Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 297. United States Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 298. United States Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 299. Canada Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 300. Canada Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 301. Canada Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 302. Canada Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 303. Canada Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 304. Mexico Lateral Flow Assay Sales, by Type K Units (2014-2019)
  • Table 305. Mexico Lateral Flow Assay Sales, by End Users K Units (2014-2019)
  • Table 306. Mexico Lateral Flow Assay Sales, by Clinical Tests K Units (2014-2019)
  • Table 307. Mexico Lateral Flow Assay Sales, by Technique K Units (2014-2019)
  • Table 308. Mexico Lateral Flow Assay Sales, by Sales Channel K Units (2014-2019)
  • Table 309. Lateral Flow Assay: by Type(USD/Units)
  • Table 310. Company Basic Information, Sales Area and Its Competitors
  • Table 311. Company Basic Information, Sales Area and Its Competitors
  • Table 312. Company Basic Information, Sales Area and Its Competitors
  • Table 313. Company Basic Information, Sales Area and Its Competitors
  • Table 314. Company Basic Information, Sales Area and Its Competitors
  • Table 315. Company Basic Information, Sales Area and Its Competitors
  • Table 316. Company Basic Information, Sales Area and Its Competitors
  • Table 317. Company Basic Information, Sales Area and Its Competitors
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Lateral Flow Assay: by Type(USD Million)
  • Table 323. Lateral Flow Assay Kits & Reagents , by Region USD Million (2020-2025)
  • Table 324. Lateral Flow Assay Lateral Flow Readers , by Region USD Million (2020-2025)
  • Table 325. Lateral Flow Assay Digital/Mobile Readers , by Region USD Million (2020-2025)
  • Table 326. Lateral Flow Assay Benchtop Readers , by Region USD Million (2020-2025)
  • Table 327. Lateral Flow Assay: by End Users(USD Million)
  • Table 328. Lateral Flow Assay Hospitals and Clinics , by Region USD Million (2020-2025)
  • Table 329. Lateral Flow Assay Diagnostic Laboratories , by Region USD Million (2020-2025)
  • Table 330. Lateral Flow Assay Pharmaceutical and Biotech Companies , by Region USD Million (2020-2025)
  • Table 331. Lateral Flow Assay Others , by Region USD Million (2020-2025)
  • Table 332. Lateral Flow Assay: by Clinical Tests(USD Million)
  • Table 333. Lateral Flow Assay Clinical Testing { Infectious Diseases Testing, Cardiac Markers, Pregnancy & Fertility Testing, Drugs of Abuse Testing, Other} , by Region USD Million (2020-2025)
  • Table 334. Lateral Flow Assay Veterinary Diagnostics , by Region USD Million (2020-2025)
  • Table 335. Lateral Flow Assay Drug Development & Quality Testing , by Region USD Million (2020-2025)
  • Table 336. Lateral Flow Assay Food Safety & Environmental Safety , by Region USD Million (2020-2025)
  • Table 337. Lateral Flow Assay: by Technique(USD Million)
  • Table 338. Lateral Flow Assay Competitive Assays , by Region USD Million (2020-2025)
  • Table 339. Lateral Flow Assay Sandwich Assays , by Region USD Million (2020-2025)
  • Table 340. Lateral Flow Assay Multiplex Detection Assays , by Region USD Million (2020-2025)
  • Table 341. South America Lateral Flow Assay, by Country USD Million (2020-2025)
  • Table 342. South America Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 343. South America Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 344. South America Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 345. South America Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 346. South America Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 347. Brazil Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 348. Brazil Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 349. Brazil Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 350. Brazil Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 351. Brazil Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 352. Argentina Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 353. Argentina Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 354. Argentina Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 355. Argentina Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 356. Argentina Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 357. Rest of South America Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 358. Rest of South America Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 359. Rest of South America Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 360. Rest of South America Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 361. Rest of South America Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 362. Asia Pacific Lateral Flow Assay, by Country USD Million (2020-2025)
  • Table 363. Asia Pacific Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 364. Asia Pacific Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 365. Asia Pacific Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 366. Asia Pacific Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 367. Asia Pacific Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 368. China Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 369. China Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 370. China Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 371. China Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 372. China Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 373. Japan Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 374. Japan Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 375. Japan Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 376. Japan Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 377. Japan Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 378. India Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 379. India Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 380. India Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 381. India Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 382. India Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 383. South Korea Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 384. South Korea Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 385. South Korea Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 386. South Korea Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 387. South Korea Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 388. Taiwan Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 389. Taiwan Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 390. Taiwan Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 391. Taiwan Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 392. Taiwan Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 393. Australia Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 394. Australia Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 395. Australia Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 396. Australia Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 397. Australia Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 398. Rest of Asia-Pacific Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 399. Rest of Asia-Pacific Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 400. Rest of Asia-Pacific Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 401. Rest of Asia-Pacific Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 402. Rest of Asia-Pacific Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 403. Europe Lateral Flow Assay, by Country USD Million (2020-2025)
  • Table 404. Europe Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 405. Europe Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 406. Europe Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 407. Europe Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 408. Europe Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 409. Germany Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 410. Germany Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 411. Germany Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 412. Germany Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 413. Germany Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 414. France Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 415. France Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 416. France Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 417. France Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 418. France Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 419. Italy Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 420. Italy Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 421. Italy Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 422. Italy Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 423. Italy Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 424. United Kingdom Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 425. United Kingdom Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 426. United Kingdom Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 427. United Kingdom Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 428. United Kingdom Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 429. Netherlands Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 430. Netherlands Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 431. Netherlands Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 432. Netherlands Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 433. Netherlands Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 434. Rest of Europe Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 435. Rest of Europe Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 436. Rest of Europe Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 437. Rest of Europe Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 438. Rest of Europe Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 439. MEA Lateral Flow Assay, by Country USD Million (2020-2025)
  • Table 440. MEA Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 441. MEA Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 442. MEA Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 443. MEA Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 444. MEA Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 445. Middle East Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 446. Middle East Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 447. Middle East Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 448. Middle East Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 449. Middle East Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 450. Africa Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 451. Africa Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 452. Africa Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 453. Africa Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 454. Africa Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 455. North America Lateral Flow Assay, by Country USD Million (2020-2025)
  • Table 456. North America Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 457. North America Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 458. North America Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 459. North America Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 460. North America Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 461. United States Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 462. United States Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 463. United States Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 464. United States Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 465. United States Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 466. Canada Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 467. Canada Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 468. Canada Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 469. Canada Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 470. Canada Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 471. Mexico Lateral Flow Assay, by Type USD Million (2020-2025)
  • Table 472. Mexico Lateral Flow Assay, by End Users USD Million (2020-2025)
  • Table 473. Mexico Lateral Flow Assay, by Clinical Tests USD Million (2020-2025)
  • Table 474. Mexico Lateral Flow Assay, by Technique USD Million (2020-2025)
  • Table 475. Mexico Lateral Flow Assay, by Sales Channel USD Million (2020-2025)
  • Table 476. Lateral Flow Assay Sales: by Type(K Units)
  • Table 477. Lateral Flow Assay Sales Kits & Reagents , by Region K Units (2020-2025)
  • Table 478. Lateral Flow Assay Sales Lateral Flow Readers , by Region K Units (2020-2025)
  • Table 479. Lateral Flow Assay Sales Digital/Mobile Readers , by Region K Units (2020-2025)
  • Table 480. Lateral Flow Assay Sales Benchtop Readers , by Region K Units (2020-2025)
  • Table 481. Lateral Flow Assay Sales: by End Users(K Units)
  • Table 482. Lateral Flow Assay Sales Hospitals and Clinics , by Region K Units (2020-2025)
  • Table 483. Lateral Flow Assay Sales Diagnostic Laboratories , by Region K Units (2020-2025)
  • Table 484. Lateral Flow Assay Sales Pharmaceutical and Biotech Companies , by Region K Units (2020-2025)
  • Table 485. Lateral Flow Assay Sales Others , by Region K Units (2020-2025)
  • Table 486. Lateral Flow Assay Sales: by Clinical Tests(K Units)
  • Table 487. Lateral Flow Assay Sales Clinical Testing { Infectious Diseases Testing, Cardiac Markers, Pregnancy & Fertility Testing, Drugs of Abuse Testing, Other} , by Region K Units (2020-2025)
  • Table 488. Lateral Flow Assay Sales Veterinary Diagnostics , by Region K Units (2020-2025)
  • Table 489. Lateral Flow Assay Sales Drug Development & Quality Testing , by Region K Units (2020-2025)
  • Table 490. Lateral Flow Assay Sales Food Safety & Environmental Safety , by Region K Units (2020-2025)
  • Table 491. Lateral Flow Assay Sales: by Technique(K Units)
  • Table 492. Lateral Flow Assay Sales Competitive Assays , by Region K Units (2020-2025)
  • Table 493. Lateral Flow Assay Sales Sandwich Assays , by Region K Units (2020-2025)
  • Table 494. Lateral Flow Assay Sales Multiplex Detection Assays , by Region K Units (2020-2025)
  • Table 495. South America Lateral Flow Assay Sales, by Country K Units (2020-2025)
  • Table 496. South America Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 497. South America Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 498. South America Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 499. South America Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 500. South America Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 501. Brazil Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 502. Brazil Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 503. Brazil Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 504. Brazil Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 505. Brazil Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 506. Argentina Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 507. Argentina Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 508. Argentina Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 509. Argentina Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 510. Argentina Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 511. Rest of South America Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 512. Rest of South America Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 513. Rest of South America Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 514. Rest of South America Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 515. Rest of South America Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 516. Asia Pacific Lateral Flow Assay Sales, by Country K Units (2020-2025)
  • Table 517. Asia Pacific Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 518. Asia Pacific Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 519. Asia Pacific Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 520. Asia Pacific Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 521. Asia Pacific Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 522. China Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 523. China Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 524. China Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 525. China Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 526. China Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 527. Japan Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 528. Japan Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 529. Japan Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 530. Japan Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 531. Japan Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 532. India Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 533. India Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 534. India Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 535. India Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 536. India Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 537. South Korea Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 538. South Korea Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 539. South Korea Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 540. South Korea Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 541. South Korea Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 542. Taiwan Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 543. Taiwan Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 544. Taiwan Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 545. Taiwan Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 546. Taiwan Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 547. Australia Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 548. Australia Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 549. Australia Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 550. Australia Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 551. Australia Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 552. Rest of Asia-Pacific Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 553. Rest of Asia-Pacific Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 554. Rest of Asia-Pacific Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 555. Rest of Asia-Pacific Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 556. Rest of Asia-Pacific Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 557. Europe Lateral Flow Assay Sales, by Country K Units (2020-2025)
  • Table 558. Europe Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 559. Europe Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 560. Europe Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 561. Europe Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 562. Europe Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 563. Germany Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 564. Germany Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 565. Germany Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 566. Germany Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 567. Germany Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 568. France Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 569. France Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 570. France Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 571. France Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 572. France Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 573. Italy Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 574. Italy Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 575. Italy Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 576. Italy Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 577. Italy Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 578. United Kingdom Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 579. United Kingdom Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 580. United Kingdom Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 581. United Kingdom Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 582. United Kingdom Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 583. Netherlands Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 584. Netherlands Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 585. Netherlands Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 586. Netherlands Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 587. Netherlands Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 588. Rest of Europe Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 589. Rest of Europe Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 590. Rest of Europe Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 591. Rest of Europe Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 592. Rest of Europe Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 593. MEA Lateral Flow Assay Sales, by Country K Units (2020-2025)
  • Table 594. MEA Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 595. MEA Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 596. MEA Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 597. MEA Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 598. MEA Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 599. Middle East Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 600. Middle East Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 601. Middle East Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 602. Middle East Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 603. Middle East Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 604. Africa Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 605. Africa Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 606. Africa Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 607. Africa Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 608. Africa Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 609. North America Lateral Flow Assay Sales, by Country K Units (2020-2025)
  • Table 610. North America Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 611. North America Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 612. North America Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 613. North America Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 614. North America Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 615. United States Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 616. United States Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 617. United States Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 618. United States Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 619. United States Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 620. Canada Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 621. Canada Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 622. Canada Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 623. Canada Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 624. Canada Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 625. Mexico Lateral Flow Assay Sales, by Type K Units (2020-2025)
  • Table 626. Mexico Lateral Flow Assay Sales, by End Users K Units (2020-2025)
  • Table 627. Mexico Lateral Flow Assay Sales, by Clinical Tests K Units (2020-2025)
  • Table 628. Mexico Lateral Flow Assay Sales, by Technique K Units (2020-2025)
  • Table 629. Mexico Lateral Flow Assay Sales, by Sales Channel K Units (2020-2025)
  • Table 630. Lateral Flow Assay: by Type(USD/Units)
  • Table 631. Research Programs/Design for This Report
  • Table 632. Key Data Information from Secondary Sources
  • Table 633. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Lateral Flow Assay: by Type USD Million (2014-2019)
  • Figure 5. Global Lateral Flow Assay: by End Users USD Million (2014-2019)
  • Figure 6. Global Lateral Flow Assay: by Clinical Tests USD Million (2014-2019)
  • Figure 7. Global Lateral Flow Assay: by Technique USD Million (2014-2019)
  • Figure 8. South America Lateral Flow Assay Share (%), by Country
  • Figure 9. Asia Pacific Lateral Flow Assay Share (%), by Country
  • Figure 10. Europe Lateral Flow Assay Share (%), by Country
  • Figure 11. MEA Lateral Flow Assay Share (%), by Country
  • Figure 12. North America Lateral Flow Assay Share (%), by Country
  • Figure 13. Global Lateral Flow Assay: by Type K Units (2014-2019)
  • Figure 14. Global Lateral Flow Assay: by End Users K Units (2014-2019)
  • Figure 15. Global Lateral Flow Assay: by Clinical Tests K Units (2014-2019)
  • Figure 16. Global Lateral Flow Assay: by Technique K Units (2014-2019)
  • Figure 17. South America Lateral Flow Assay Share (%), by Country
  • Figure 18. Asia Pacific Lateral Flow Assay Share (%), by Country
  • Figure 19. Europe Lateral Flow Assay Share (%), by Country
  • Figure 20. MEA Lateral Flow Assay Share (%), by Country
  • Figure 21. North America Lateral Flow Assay Share (%), by Country
  • Figure 22. Global Lateral Flow Assay: by Type USD/Units (2014-2019)
  • Figure 23. Global Lateral Flow Assay share by Players 2019 (%)
  • Figure 24. Global Lateral Flow Assay share by Players (Top 3) 2019(%)
  • Figure 25. Global Lateral Flow Assay share by Players (Top 5) 2019(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 28. Abbott Laboratories (United States) Revenue: by Geography 2019
  • Figure 29. F. Hoffmann-La Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. F. Hoffmann-La Roche (Switzerland) Revenue: by Geography 2019
  • Figure 31. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Danaher Corporation (United States) Revenue: by Geography 2019
  • Figure 33. Siemens AG (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Siemens AG (Germany) Revenue: by Geography 2019
  • Figure 35. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 36. Becton, Dickinson and Company (United States) Revenue: by Geography 2019
  • Figure 37. BioMérieux (France) Revenue, Net Income and Gross profit
  • Figure 38. BioMérieux (France) Revenue: by Geography 2019
  • Figure 39. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 40. Bio-Rad Laboratories (United States) Revenue: by Geography 2019
  • Figure 41. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 42. Thermo Fisher Scientific (United States) Revenue: by Geography 2019
  • Figure 43. QIAGEN NV (Netherlands) Revenue, Net Income and Gross profit
  • Figure 44. QIAGEN NV (Netherlands) Revenue: by Geography 2019
  • Figure 45. PerkinElmer (United States) Revenue, Net Income and Gross profit
  • Figure 46. PerkinElmer (United States) Revenue: by Geography 2019
  • Figure 47. Hologic, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 48. Hologic, Inc. (United States) Revenue: by Geography 2019
  • Figure 49. Quidel Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 50. Quidel Corporation (United States) Revenue: by Geography 2019
  • Figure 51. Global Lateral Flow Assay: by Type USD Million (2020-2025)
  • Figure 52. Global Lateral Flow Assay: by End Users USD Million (2020-2025)
  • Figure 53. Global Lateral Flow Assay: by Clinical Tests USD Million (2020-2025)
  • Figure 54. Global Lateral Flow Assay: by Technique USD Million (2020-2025)
  • Figure 55. South America Lateral Flow Assay Share (%), by Country
  • Figure 56. Asia Pacific Lateral Flow Assay Share (%), by Country
  • Figure 57. Europe Lateral Flow Assay Share (%), by Country
  • Figure 58. MEA Lateral Flow Assay Share (%), by Country
  • Figure 59. North America Lateral Flow Assay Share (%), by Country
  • Figure 60. Global Lateral Flow Assay: by Type K Units (2020-2025)
  • Figure 61. Global Lateral Flow Assay: by End Users K Units (2020-2025)
  • Figure 62. Global Lateral Flow Assay: by Clinical Tests K Units (2020-2025)
  • Figure 63. Global Lateral Flow Assay: by Technique K Units (2020-2025)
  • Figure 64. South America Lateral Flow Assay Share (%), by Country
  • Figure 65. Asia Pacific Lateral Flow Assay Share (%), by Country
  • Figure 66. Europe Lateral Flow Assay Share (%), by Country
  • Figure 67. MEA Lateral Flow Assay Share (%), by Country
  • Figure 68. North America Lateral Flow Assay Share (%), by Country
  • Figure 69. Global Lateral Flow Assay: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • Abbott Laboratories (United States)
  • F. Hoffmann-La Roche (Switzerland)
  • Danaher Corporation (United States)
  • Siemens AG (Germany)
  • Becton, Dickinson and Company (United States)
  • bioMérieux (France)
  • Bio-Rad Laboratories (United States)
  • Thermo Fisher Scientific (United States)
  • QIAGEN NV (Netherlands)
  • PerkinElmer (United States)
  • Hologic, Inc. (United States)
  • Quidel Corporation (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation